February 18, 2021
Leading drug discovery and development partnership company Evotec deploys market-leading software platform for support of its broad and innovative assay and screening portfolio, gaining speed and efficiency Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Evotec, the global drug discovery alliance and development partnership company, has [...]
February 18, 2021
- Focus on Rare Disease Prenatal and Pediatric Genetic Screening Services - SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Victorian Clinical Genetic Services (VCGS), an Australian-based specialist provider of prenatal, childhood and adult genetics [...]
February 18, 2021
COLUMBIA, Md. — Shimadzu Scientific Instruments announces the new i-Series LC-2050/LC-2060 Integrated High-Performance Liquid Chromatographs (HPLC). Building on the exceptional performance of previous versions, the i-Series LC-2050/LC-2060 models incorporate analytical intelligence functions, enable complete automation from startup to analysis preparations, and allow remote monitoring and data processing. Analytical intelligence advancements in the i-Series systems include real-time [...]
Mutant Spike Proteins & Antigens for SARS-CoV-2 Variant Research
February 18, 2021
AMSBIO has introduced a collection of mutated SARS-CoV-2 spike proteins and recombinant antigens for the new virus variants - B.1.1.7 and B.1.351. These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines. Emerging in the latter part of 2020, multiple new [...]
Emulate Names Donald Ingber to Board of Directors
February 18, 2021
Technology Visionary will Offer Strategic Insight to Guide Ongoing Research & Development of Market Leading Organ-on-a-Chip Technology BOSTON, Mass. - Emulate, Inc., a leading provider of organ-on-a-chip technology today announced the appointment of Donald Ingber, M.D., Ph.D., to its Board of Directors. Ingber, the scientific founder of Emulate and Chairman of its Scientific Advisory Board [...]
February 18, 2021
LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. Thermo Fisher Scientific and Waters Corporation join Astellas and the Massachusetts Life Sciences Center (MSLC) as sponsors. Part [...]
February 17, 2021
Santa Barbara, CA. Oxford Instruments Asylum Research is pleased to announce the release of the NanoRack in situ tensile and compression sample stage accessory for the Jupiter XR atomic force microscope (AFM). The NanoRack is a high-strain, high-travel stage that enables polymer films, fibers and other materials to be examined in situ by AFM under [...]
February 17, 2021
Bio-Works Technologies AB has signed a licensing agreement with Amicogen Inc to establish local production of agarose resins in South Korea The contract provides up-front and milestone payments of $5 million USD and royalty payments thereafter on Amicogen’s net sales Bio-Works existing sales in South Korea are less than 1 million SEK per year, which [...]
February 17, 2021
Micro-chip based µPAC™ LC columns – key component in Vienna IMP study measuring the proteome at picogram level GHENT, BELGIUM -- PharmaFluidics NV, innovative life sciences instruments player, is excited to announce that researchers of Karl Mechtler’s Group at the Research Institute for Molecular Pathology in Vienna have integrated its ultra-sensitive second generation µPAC™ micro-Chip [...]
February 17, 2021
Eight-marker panel, including new long mononucleotide repeat (LMR) markers, enables broader view of mismatch repair deficiency Madison, WI USA. A new microsatellite instability (MSI) system launched today by Promega Corporation enables cancer researchers to evaluate a new set of unique MSI markers that may offer additional precision in the characterization of their tumor samples. MSI [...]

